Jones Day’s Milan Office opened in 2001 and has steadily grown to its present size of approximately 40 professionals. We are strategically located in the commercial and financial center of Italy and advise Italian and international clients on a comprehensive range of legal matters.
Our Milan Office advises clients on corporate and commercial matters, with particular emphasis on the following areas of law: Antitrust & Competition; Banking & Finance, including banking litigation; Business Restructuring & Reorganization, including pre-insolvency and insolvency matters for issues related to structured finance products and derivatives; Capital Markets; Cybersecurity, Privacy & Data Protection; Employee Benefits & Executive Compensation; Energy; Intellectual Property; Global Disputes, Labor & Employment, Mergers & Acquisitions, including joint ventures; Private Equity including Fund Formation; Real Estate including finance; and Tax.
Our lawyers have deep experience of legal issues affecting many industries, including automotive, chemicals, construction, consumer products, energy, fashion, financial services, health care, insurance, media, pharmaceuticals, and telecommunications.
The Milan Office and its attorneys are fully integrated into the Firm's global organization of more than 2,500 lawyers in offices across the Americas, Europe, the Middle East, Asia, and Australia. Jones Day's One Firm Worldwide approach to legal service provides our clients not only an international reach, but also seamless, efficient access to substantial legal resources wherever needed.
The Milan Office's strong commitment to clients is equaled by our commitment to the community. We provide pro bono support and advice to major Italian non-profit organizations like Pangea, active in the protection of women and children’s rights; Vidas, which is dedicated to assisting terminally ill patients and their families; and Emergenza Sorrisi, which assists children affected by cleft lip/palate, face malformation, burns, war trauma, tumors, orthopedic and ophthalmic diseases.